Although Ivermectin is generally tolerated at moderate doses, side-effects could increase as the doses are increased; higher concentrations of Ivermectin is needed to be administered in patients’ lungs for it to be effective against the virus, said Dr Jagadish Hiremath, medical director at Ace Multi-Speciality Hospital. “We have to wait for a more conclusive clinical trial on a large and diverse subset of the population, which will give us clarity on its usage,” he said.
Image used for representational purpose only
BENGALURU: At least eight Covid-19 patients in the city have received a monoclonal antibody cocktail called Casirivimab and Imdevimab. The new drug, which comes in the form of two doses of Rs 60,000 each, offers hope to comorbid patients who have mild to moderate coronavirus infection but face higher risk of developing complications.
Of the eight, two got the drug at St John’s Medical College Hospital on Tuesday. The two men, aged 52 and 38, had undergone a kidney transplant earlier, and have been given the dose to prevent their mild symptoms from turning into a severe infection.
Apollo Hospitals starts vaccination for those above 18 years
Updated:
Updated:
Share Article
AAA
Apollo Speciality Hospitals in Madurai has started the third phase of vaccination for citizens aged above 18 years.
A press release from the Chief Operating Officer of Apollo Hospitals Rohini Sridhar said that the beneficiaries are required to register on the CoWIN app or Aarogya Setu app to book their appointment slot before arriving for the vaccination.
In the second wave of infections, more younger patients were getting affected and thus vaccinating everyone aged above 18 was an important precautionary measure. Till now, around 3,000 persons aged 45 and above have been vaccinated in the hospital, added the press release.